Literature DB >> 2935409

Characterization of [3H]paroxetine binding to rat cortical membranes.

E Habert, D Graham, L Tahraoui, Y Claustre, S Z Langer.   

Abstract

Paroxetine is a selective and potent inhibitor of 5-hydroxytryptamine uptake into serotonergic neurons. The specific binding of [3H]paroxetine to rat cortical membranes at 22 degrees C was examined in this study. Our results indicate the presence of a single saturable high affinity binding component for [3H]paroxetine. Scatchard analysis revealed a Kd of 0.15 +/- 0.01 nM, and a Bmax of 549 +/- 36 fmol/mg protein. The kinetically derived dissociation constant was 0.034 +/- 0.008 nM. [3H]Paroxetine binding was inhibited selectively by 5-HT uptake blockers, and a good correlation was demonstrated between the potency of various drugs to inhibit [3H]paroxetine binding and [3H]5-hydroxytryptamine uptake. Also, lesions performed with the neurotoxin, 5,7-dihydroxytryptamine resulted in a 94% decrease in endogenous 5-hydroxytryptamine levels and concomitantly, a 90% reduction in [3H]paroxetine binding when compared to sham controls. These results indicate that the binding site labelled by [3H]paroxetine is associated with the neuronal 5-hydroxytryptamine transporter complex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935409     DOI: 10.1016/0014-2999(85)90668-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  31 in total

1.  Drug inhibition indicates a single-site model of the 5-HT uptake site/antidepressant binding site in rat and human brain.

Authors:  J O Marcusson; A Andersson; I Bäckström
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy").

Authors:  J Sharkey; D E McBean; P A Kelly
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Increased uptake sites for serotonin and dopamine with decreased S2 serotonin receptors in microencephalic rat brain.

Authors:  M Watanabe; M Kinuya; G Mamiya; T Tatsunuma; M Nagayoshi; T Matsutani; Y Tsukada
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

4.  Boron-Doped Diamond Microelectrodes Reveal Reduced Serotonin Uptake Rates in Lymphocytes from Adult Rhesus Monkeys Carrying the Short Allele of the 5-HTTLPR.

Authors:  Yogesh S Singh; Lauren E Sawarynski; Heather M Michael; Robert E Ferrell; Michael A Murphey-Corb; Greg M Swain; Bhavik A Patel; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2010-01-20       Impact factor: 4.418

5.  The distribution of serotonergic nerves in microencephalic rats treated prenatally with methylazoxymethanol.

Authors:  Y Kodama; R Nonaka; Y Hagino; M Watanabe
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

6.  Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.

Authors:  A Doble; D Girdlestone; O Piot; D Allam; J Betschart; A Boireau; A Dupuy; C Guérémy; J Ménager; J L Zundel
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

7.  Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites.

Authors:  J J Mann; R A Henteleff; T F Lagattuta; J A Perper; S Li; V Arango
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain.

Authors:  P Blier; Y Chaput; C de Montigny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

9.  Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments.

Authors:  F Molina-Holgado; E Molina-Holgado; M L Leret; M I González; T A Reader
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

10.  Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs.

Authors:  T Mennini; A Bizzi; S Caccia; A Codegoni; C Fracasso; E Frittoli; G Guiso; I M Padura; C Taddei; A Uslenghi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.